Review of Brain-Computer Interface Applications in the Treatment of Amyotrophic Lateral Sclerosis

Research Article
Open access

Review of Brain-Computer Interface Applications in the Treatment of Amyotrophic Lateral Sclerosis

Xinran Zhang 1*
  • 1 Tianyi High School    
  • *corresponding author Ariazhangxinran@163.com
Published on 12 December 2024 | https://doi.org/10.54254/2753-8818/2024.17984
TNS Vol.63
ISSN (Print): 2753-8818
ISSN (Online): 2753-8826
ISBN (Print): 978-1-83558-729-4
ISBN (Online): 978-1-83558-730-0

Abstract

This paper explores the transformative potential of Brain-Computer Interface (BCI) technology in the context of Amyotrophic Lateral Sclerosis (ALS) treatment. ALS is a progressive neurodegenerative disease that severely limits motor function and communication abilities. It necessitates innovative solutions beyond current palliative care. BCIs offer direct brain-to-device communication, enabling ALS patients to regain autonomy through tasks like communication, environmental control, and mobility. This paper synthesizes recent advancements in BCI technology relevant to ALS, discussing non-invasive and invasive approaches, functional applications, and current research challenges. It emphasizes the benefits of BCIs in enhancing quality of life and mental well-being for ALS patients while also addressing ethical considerations such as informed consent and data privacy. Future directions include hybrid BCI development, machine learning integration, and equitable access strategies. By identifying current progress and remaining hurdles, this review aims to inform ongoing research efforts and policy development toward more effective and inclusive ALS treatments.

Keywords:

Amyotropic Lateral Sclerosis, Brain-Computer Interface, treatment, medical applications

Zhang,X. (2024). Review of Brain-Computer Interface Applications in the Treatment of Amyotrophic Lateral Sclerosis. Theoretical and Natural Science,63,118-122.
Export citation

1. Introduction

Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease caused by the progressive degeneration of motor neurons. Common symptoms include severe muscle weakness, paralysis, and respiratory failure. Although there have been many research on its pathophysiology and treatment, current therapies remain palliative. As a result, innovative approaches are urgently needed. One such promising innovation is Brain-Computer Interface (BCI) technology. It facilitates direct communication between the brain and external devices. Recent advancements in BCI have shown significant potential in various medical applications, including neurorehabilitation, communication aids, and motor function restoration. However, there are still many problems yet to be addressed.

This paper aims to provide a comprehensive review of BCI applications in the treatment of ALS, highlighting current research progress and identifying gaps that need to be addressed to advance the field. Specifically, the paper will mainly explore the current advancements in BCI technology relevant to ALS treatment, examine how BCIs have been used to aid ALS patients in communication and motor function restoration, discuss key challenges and limitations in implementing BCIs for ALS patients, and suggest future research directions to enhance the effectiveness and applicability of BCIs in ALS treatment. The paper will use a comprehensive review methodology. It will analyze recent literature, case studies, and clinical trials related to BCI applications in ALS. By synthesizing findings from various sources, this review will provide a detailed overview of BCI technologies.

The significance of this research is to help find new therapies for ALS patients. By identifying current progress and gaps, this paper will offer insights into the application of BCI to ALS patients. As the field progresses, these insights could promote the development of more effective and accessible BCI solutions, which will benefit ALS patients a lot.

2. The Relevance of BCIs in ALS

2.1. The importance of BCIs for ALS patients

ALS progressively robs individuals of their muscle function. Therefore, patients have severe physical limitations. This devastating impact makes the development of assistive technologies very important. BCIs allow ALS patients to communicate and interact with their environment through brain signals alone. This technology can significantly improve patients’ quality of life by restoring a degree of autonomy that would otherwise be lost. For ALS patients, traditional communication methods, like speech or typing, eventually become impossible. BCIs bypass these barriers, enabling patients to express their thoughts and needs without relying on muscular control. This direct brain-to-device communication can facilitate various functions, including controlling a computer cursor, operating a wheelchair, or even spelling out words and sentences [1].

2.2. Potential benefits

The benefits of BCIs for ALS patients extend beyond basic communication. They can also enhance their ability to control the environment. Therefore, BCIs can provide patients with a sense of independence and help reduce the burden on caregivers. For example, they can be used to control home automation systems, allowing patients to manage lights, temperature, and other household devices [2]. Additionally, BCIs can let ALS patients engage in entertainment and social activities, thereby improving their mental health and overall well-being. Moreover, BCIs offer continuous cognitive engagement, which is important for maintaining mental sharpness and combating the isolation that often accompanies severe physical disabilities. The ability to interact with technology and the environment can contribute to a sense of purpose and motivation, which are essential for psychological health [3].

3. Types of BCI Applications in ALS

3.1. Invasiveness

BCIs can be categorized based on their level of invasiveness.

Non-invasive BCIs are commonly preferred due to their lower risk and ease of use. Examples include those using EEG. Electrodes are placed on the patient’s scalp to detect electrical activity in the brain. Although non-invasive BCIs are generally less accurate than their invasive counterparts, they are safer and more accessible for ALS patients [4].

On the other hand, invasive BCIs involve implanting electrodes directly into the brain. But they offer higher precision and reliability. They can provide more detailed brain signals. Thus, invasive BCIs usually have better control and a faster response. An example is the fully implanted BCI described by Vansteensel [5]. In this case, electrodes were placed over the motor cortex to enable a patient with late-stage ALS to communicate by typing on a computer.

3.2. Functions

BCIs can be designed for various functions, each tailored to meet the specific needs of ALS patients.

Communication BCIs allow users to spell out words and sentences by selecting letters on a virtual keyboard. The cVEP speller developed by Verbaarschot is an example [1]. It shows high accuracy and speed in both healthy participants and ALS patients.

Another important function is environmental control. BCIs can be integrated with smart home systems to allow ALS patients to manage household devices independently. This integration can greatly enhance the quality of life by providing greater autonomy and reducing reliance on caregivers [2].

Additionally, BCIs can be used for mobility, enabling patients to control wheelchairs or robotic limbs. This application is particularly beneficial for maintaining physical activity and independence. Advances in machine learning and signal processing are continuously improving the performance of these systems, making them more reliable and user-friendly.

4. Research and Development

Early research mostly focused on healthy people to improve the algorithms and hardware. As the technology improved, researchers started testing it with ALS patients to see how well it worked in real life. One important study by Verbaarschot tested a cVEP speller on 20 healthy people and 10 ALS patients [1]. They found that ALS patients could reach an average accuracy of 79% in spelling tasks, showing the potential of cVEP BCIs for communication. Researchers have also looked into different types of brain signals to make BCIs work better. For example, McFarland talked about using EEG to detect brain signals non-invasively, while other studies explored using electrocorticography (ECoG) for more precise control [4]. The choice between these signals often depends on balancing invasiveness and performance.

With ongoing research, BCI technology can also include hybrid systems that combine different signal types to improve accuracy and reliability. For instance, combining EEG with functional near-infrared spectroscopy (fNIRS) can improve signal detection and interpretation, leading to better performance in real-life situations [6]. These hybrid systems are still being studied, but they show promising early results.

Additionally, the development of BCI technology for ALS has been influenced by the psychological and motivational states of users. Nijboer highlighted that factors like mood, motivation, and quality of life significantly affect BCI performance [3]. Their research suggests that personalized training that takes these psychological factors into account can lead to better results for ALS patients.

Another important area of research has been integrating BCIs with other assistive technologies. For example, BCIs can control robotic limbs or wheelchairs, giving ALS patients more mobility and independence [2]. This integration requires advanced algorithms that can turn brain signals into precise commands for these devices, a field that is rapidly advancing.

5. Future Directions

The future of BCI technology for ALS looks very promising. Researchers are working on new ideas to make BCIs better and easier to use. One exciting development is hybrid BCIs. These combine different types of brain signals, like EEG and fNIRS, to improve accuracy and reduce noise [6]. Another promising area is the use of advanced machine learning in BCIs. These algorithms learn from user interactions, adapting to individual needs and improving signal interpretation over time. This personalized approach can reduce training time and make BCIs more intuitive for users [7]. Additionally, artificial intelligence can create better models for translating brain signals into commands, enhancing BCI functionality.

The ethical and societal implications of this technology are also important areas for future research. Issues like informed consent, data privacy, and the potential for misuse must be addressed [8]. Clear guidelines and policies are needed to ensure BCIs are used responsibly and fairly. This includes standards for the ethical use of invasive BCIs and ensuring non-invasive options are available for those who prefer them. Moreover, accessibility and affordability are also key considerations. It's important that all ALS patients can benefit from these advancements, regardless of their financial status. This might involve developing cost-effective BCI systems or providing funding to support patients who need them. Chandler emphasizes the importance of equitable access to these life-changing technologies [2].

Expanding BCI applications beyond communication and basic control functions can further improve the quality of life for ALS patients. For instance, BCIs could be integrated with smart home systems, allowing users to control household devices seamlessly. They could also be used for cognitive assessment and rehabilitation, offering a comprehensive approach to managing ALS [7]. Plus, continuous interdisciplinary collaboration is necessary. Combining expertise from neuroscience, engineering, computer science, and ethics will enable the development of more sophisticated, user-centered BCI systems. As research progresses, these collaborative efforts will likely lead to breakthroughs that make BCIs more effective and widely available for ALS patients.

6. Ethical and Social Implications

Although BCI technology is a useful tool to treat ALS, it also raises ethical and social issues.

First, getting informed consent is a big ethical concern. ALS patients, especially those in advanced stages, may have trouble communicating and understanding things, making it hard to ensure they fully agree to use BCI technology. Vlek stresses the need for clear and simple consent processes that address the unique challenges faced by ALS patients [9]. This includes using easy-to-understand language and making sure patients know the possible risks and benefits of using BCIs. Another ethical issue is the risk of increasing social inequalities. BCIs are advanced and expensive, and not all ALS patients, especially those from lower-income backgrounds, can afford them. Chandler highlights the need for policies that ensure everyone has access to these technologies [2]. It is important to make sure all patients, no matter their financial situation, can benefit from BCIs to prevent a gap where only wealthy patients can access this life-changing technology. Privacy and data security are also major concerns. BCIs collect sensitive brain data, and if this data is not handled properly, it could lead to privacy breaches. McCullagh emphasizes the importance of having strong data protection measures to keep patients' information safe [6]. This includes securely storing data and making sure only authorized people can access it to prevent misuse and unauthorized access. There is also the ethical issue of possible misuse of BCI technology. While BCIs are meant to help ALS patients, there is a risk they could be used for other purposes, like enhancing cognitive abilities or surveillance. Mikołajewska and Mikołajewski discuss the need for clear rules and guidelines to prevent such misuse. Setting ethical guidelines and regulations can help ensure BCIs are used responsibly and only for their intended purposes [8].

On the other hand, this kind of treatment also has social benefits. Socially, using BCIs for ALS treatment can greatly improve patients' quality of life. BCIs provide a way for patients to communicate and interact when they might otherwise be isolated due to their condition. Nijboer found that BCIs could greatly enhance the quality of life for ALS patients by giving them a way to express themselves and interact with their surroundings [3]. This technology can reduce feelings of isolation and improve mental health by helping patients engage in social activities and maintain relationships. Moreover, integrating BCIs into daily life can change how care is provided to ALS patients. It can lessen the burden on caregivers by giving patients more independence and control over their environment. This can lead to better relationships between patients and caregivers, as patients can regain a sense of independence and dignity. Finally, it is important for society to accept BCI technology. Public awareness and understanding of BCIs can influence how these technologies are seen and used. Educating the public about the benefits and ethical considerations of BCIs can create a more inclusive environment for ALS patients using these technologies. Support from the community can help integrate BCIs into mainstream healthcare, promoting a more supportive system for patients.

7. Conclusion

BCI technology represents a transformative advancement in the treatment of ALS. It offers new possibilities for improving the quality of life and functional capabilities of patients. By enabling direct communication and control through brain signals, BCIs can bypass the severe physical limitations caused by ALS. As a result, they can help patients maintain autonomy and engagement. Current research has highlighted the potential benefits of BCIs, such as enhanced communication, environmental control, and mobility for ALS patients. However, significant challenges remain in terms of accuracy, user experience, and ethical considerations. Issues like the invasiveness of certain BCI approaches, the variability in user performance, and concerns around informed consent and data privacy require ongoing attention.

As the field progresses, addressing these challenges will be essential to fully realizing the potential of BCIs. Future advancements in hybrid BCIs, which combine different types of brain signals to improve accuracy and reliability, and the integration of machine learning algorithms to personalize the user experience are promising areas of development. Additionally, establishing robust ethical guidelines and ensuring equitable access to BCI technology will be important in making these innovations widely available to all ALS patients, regardless of financial status.

In conclusion, while BCIs are not yet a panacea for ALS, they represent a critical step forward in providing life-enhancing interventions. Continued efforts to refine the technology, address ethical and accessibility concerns, and foster interdisciplinary collaboration will be vital to unlocking the full potential of BCIs for the treatment of ALS. As research and development advance, BCIs could become an integral component of comprehensive ALS care, significantly improving patients' quality of life.


References

[1]. Verbaarschot, C., Tump, D., Lutu, A., Borhanazad, M., Thielen, J., van den Broek, P., Farquhar, J., Weikamp, J., Raaphorst, J., Groothuis, J. T., & Desain, P. (2021). A visual brain-computer interface as communication aid for patients with amyotrophic lateral sclerosis. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 132(10), 2404–2415. https://doi.org/10.1016/j.clinph.2021.07.012

[2]. Chandler, J. A., Van der Loos, K. I., Boehnke, S., Beaudry, J. S., Buchman, D. Z., & Illes, J. (2022). Brain Computer Interfaces and Communication Disabilities: Ethical, legal, and social aspects of decoding speech from the brain. Frontiers in human neuroscience, 16. https://doi.org/10.3389/fnhum.2022.841035

[3]. Nijboer, F., Birbaumer, N., & Kübler, A. (2010). The influence of psychological state and motivation on brain-computer interface performance in patients with amyotrophic lateral sclerosis - a longitudinal study. Frontiers in Neuroscience, 4, 55. https://doi.org/10.3389/fnins.2010.00055

[4]. McFarland D. J. (2020). Brain-computer interfaces for amyotrophic lateral sclerosis. Muscle & Nerve, 61(6), 702–707. https://doi.org/10.1002/mus.26828

[5]. Vansteensel, M. J., Pels, E. G. M., Bleichner, M. G., Branco, M. P., Denison, T., Freudenburg, Z. V., Gosselaar, P., Leinders, S., Ottens, T. H., Van Den Boom, M. A., Van Rijen, P. C., Aarnoutse, E. J., & Ramsey, N. F. (2016). Fully implanted brain-computer interface in a locked-in patient with ALS. The New England journal of medicine, 375(21), 2060–2066. https://doi.org/10.1056/NEJMoa1608085

[6]. McCullagh, P., Lightbody, G., Zygierewicz, J., & Kernohan, W. G. (2013). Ethical Challenges Associated with the Development and Deployment of Brain Computer Interface Technology. Neuroethics, 7(2), 109–122. https://doi.org/10.1007/s12152-013-9188-6

[7]. Cipresso, P., Carelli, L., Solca, F., Meazzi, D., Meriggi, P., Poletti, B., … Riva, G. (2012). The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment. Brain and Behavior, 2(4), 479–498. https://doi.org/10.1002/brb3.57

[8]. Mikołajewska, E., & Mikołajewski, D. (2013). Ethical considerations in the use of brain-computer interfaces. Open Medicine, 8(6). https://doi.org/10.2478/s11536-013-0210-5

[9]. Vlek, R. J., Steines, D., Szibbo, D., Kübler, A., Schneider, M.-J., Haselager, P., & Nijboer, F. (2012). Ethical Issues in Brain–Computer Interface Research, Development, and Dissemination. Journal of Neurologic Physical Therapy, 36(2), 94–99. https://doi.org/10.1097/npt.0b013e31825064


Cite this article

Zhang,X. (2024). Review of Brain-Computer Interface Applications in the Treatment of Amyotrophic Lateral Sclerosis. Theoretical and Natural Science,63,118-122.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science

ISBN:978-1-83558-729-4(Print) / 978-1-83558-730-0(Online)
Editor:Alan Wang
Conference website: https://2024.icbiomed.org/
Conference date: 25 October 2024
Series: Theoretical and Natural Science
Volume number: Vol.63
ISSN:2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).

References

[1]. Verbaarschot, C., Tump, D., Lutu, A., Borhanazad, M., Thielen, J., van den Broek, P., Farquhar, J., Weikamp, J., Raaphorst, J., Groothuis, J. T., & Desain, P. (2021). A visual brain-computer interface as communication aid for patients with amyotrophic lateral sclerosis. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 132(10), 2404–2415. https://doi.org/10.1016/j.clinph.2021.07.012

[2]. Chandler, J. A., Van der Loos, K. I., Boehnke, S., Beaudry, J. S., Buchman, D. Z., & Illes, J. (2022). Brain Computer Interfaces and Communication Disabilities: Ethical, legal, and social aspects of decoding speech from the brain. Frontiers in human neuroscience, 16. https://doi.org/10.3389/fnhum.2022.841035

[3]. Nijboer, F., Birbaumer, N., & Kübler, A. (2010). The influence of psychological state and motivation on brain-computer interface performance in patients with amyotrophic lateral sclerosis - a longitudinal study. Frontiers in Neuroscience, 4, 55. https://doi.org/10.3389/fnins.2010.00055

[4]. McFarland D. J. (2020). Brain-computer interfaces for amyotrophic lateral sclerosis. Muscle & Nerve, 61(6), 702–707. https://doi.org/10.1002/mus.26828

[5]. Vansteensel, M. J., Pels, E. G. M., Bleichner, M. G., Branco, M. P., Denison, T., Freudenburg, Z. V., Gosselaar, P., Leinders, S., Ottens, T. H., Van Den Boom, M. A., Van Rijen, P. C., Aarnoutse, E. J., & Ramsey, N. F. (2016). Fully implanted brain-computer interface in a locked-in patient with ALS. The New England journal of medicine, 375(21), 2060–2066. https://doi.org/10.1056/NEJMoa1608085

[6]. McCullagh, P., Lightbody, G., Zygierewicz, J., & Kernohan, W. G. (2013). Ethical Challenges Associated with the Development and Deployment of Brain Computer Interface Technology. Neuroethics, 7(2), 109–122. https://doi.org/10.1007/s12152-013-9188-6

[7]. Cipresso, P., Carelli, L., Solca, F., Meazzi, D., Meriggi, P., Poletti, B., … Riva, G. (2012). The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment. Brain and Behavior, 2(4), 479–498. https://doi.org/10.1002/brb3.57

[8]. Mikołajewska, E., & Mikołajewski, D. (2013). Ethical considerations in the use of brain-computer interfaces. Open Medicine, 8(6). https://doi.org/10.2478/s11536-013-0210-5

[9]. Vlek, R. J., Steines, D., Szibbo, D., Kübler, A., Schneider, M.-J., Haselager, P., & Nijboer, F. (2012). Ethical Issues in Brain–Computer Interface Research, Development, and Dissemination. Journal of Neurologic Physical Therapy, 36(2), 94–99. https://doi.org/10.1097/npt.0b013e31825064